Year
|
Title
|
Authors
|
Publication
|
2021
|
A unified approach to sample size and power determination for testing parameters in generalized linear and time-to-event regression models.
|
Martens MJ, Logan BR
|
Stat Med 40(5):1121-1132
|
2021
|
Alternative donor transplantation for myelodysplastic syndromes: Haploidentical relative and matched unrelated donors.
|
Grunwald MR, Zhang M-J, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf D, Eapen M
|
Blood Adv 5(4):975-983
|
2021
|
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
|
Qayed M, Ahn KW, Kitko CL, Johnson MH, Shah NN, Dvorak CC, Mellgren KM, Friend BD, Verneris MR, Leung W, Toporski J, Levine JE, Chewning JH, Wayne AS, Kapoor U, Triplett BM, Schultz KR, Yanik GA, Eapen M
|
Blood 137(7):983-993
|
2021
|
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
|
Hong S, Brazauskas R, Hebert KM, Ganguly S, Abdel-Azim H, Diaz MA, Beattie S, Ciurea SO, Szwajcer D, Badawy SM, Gratwohl AA, LeMaistre C, Aljurf MDSM, Olsson RF, Bhatt NS, Farhadfar N, Yared JA, Yoshimi A, Seo S, Gergis U, Beitinjaneh AM, Sharma A, Lazarus H, Law J, Ulrickson M, Hashem H, Schoemans H, Cerny J, Rizzieri D, Savani BN, Kamble RT, Shaw BE, Khera N, Wood WA, Hashmi S, Hahn T, Lee SJ, Rizzo JD, Majhail NS, Saber W
|
Cancer 127(4):609-618
|
2021
|
Is there still a role for allogeneic transplantation in the management of lymphoma?
|
Shah NN, Hamadani M
|
J Clin Oncol 39(5):487-498
|
2021
|
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: A CIBMTR analysis.
|
Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann SN, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR
|
Bone Marrow Transplant 56(2):522
|
2021
|
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee.
|
Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ
|
Bone Marrow Transplant
|
2021
|
Acute GVHD diagnosis and adjudication in a multicenter trial: A report from the BMT CTN 1202 Biorepository Study.
|
Reshef R, Saber W, Bolaños-Meade J, Chen G, Chen Y-B, Ho VT, Ponce DM, Nakamura R, Martens MJ, Hansen JA, Levine JE
|
J Clin Oncol
|
2021
|
Neighborhood-poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: A CIBMTR analysis.
|
Bona K, Brazauskas R, He N, Lehmann LE, Abdel-Azim H, Ahmed I, Al-Homsi AS, Aljurf M, Arnold SD, Badawy SM, Battiwalla M, Beattie S, Bhatt NS, Dalal J, Dandoy CE, Diaz MA, Frangoul H, Freytes CO, Ganguly S, George B, Gomez-Almaguer D, Hahn T, Kamble R, Knight JM, LeMaistre CF, Law J, Lazarus HM, Majhail NS, Olsson RF, Preussler JM, Savani BN, Schears R, Seo S, Sharma A, Srivastava A, Steinberg A, Szwajcer D, Wirk B, Yoshimi A, Khera N, Wood WA, Hashmi S, Duncan C, Saber W
|
Blood 137(4):556-568
|
2021
|
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.
|
Shalabi H, Gust J, Taraseviciute A, Wolters PL, Leahy AB, Sandi C, Laetsch TW, Wiener L, Gardner RA, Nussenblatt V, Hill JA, Curran KJ, Olson TS, Annesley C, Wang H-W, Khan J, Pasquini MC, Duncan C, Grupp S, Pulsipher MA, Shah NN
|
Nat Rev Clin Oncol
|
2021
|
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: The BMT CTN 1101 trial.
|
Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG
|
Blood 137(3):420-428
|
2021
|
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
|
Sharma A, Bhatt NS, St. Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales M-A, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL
|
Lancet Haematol
|
2021
|
Haplotype motif-based models for KIR-genotype informed selection of hematopoietic cell donors fail to predict outcome of patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
|
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M
|
Front Immunol 11:584520
|
2021
|
Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post–unrelated HCT.
|
Wang Y, Zhou W, Wang J, Karaesman E, Tang H, McCarthy PL, Pasquini MC, Wang Y, McReynolds LJ, Katki HA, Machiela MJ, Yeager M, Pooler L, Sheng X, Haiman CA, Van Den Berg D, Spellman SR, Wang T, Kuxhausen M, Chanock SJ, Lee SJ, Clay-Gilmore AI, Hahn TE, Gadalla SM, Sucheston-Campbell LE
|
Blood Adv 5(1):66-70
|
2021
|
Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.
|
Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon Y-T, Carlson K-S, Nazha A, Saber W
|
Leuk Lymphoma 62(1):229-233
|
2021
|
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
|
Badar T, Hari P, Dávila O, Fraser R, Wirk B, Dhakal B, Freytes CO, Rodriguez Valdes C, Lee C, Vesole DH, Malek E, Hildebrandt GC, Landau H, Murthy HS, Lazarus HM, Berdeja JG, Meehan KR, Solh M, Diaz MA, Kharfan-Dabaja MA, Callander NS, Farhadfar N, Bashir Q, Kamble RT, Vij R, Munker R, Kyle RA, Chhabra S, Hashmi S, Ganguly S, Jagannath S, Nishihori T, Nieto Y, Kumar S, Shah N, D'Souza A
|
Cancer 127(1):82-92
|
2021
|
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
|
Costa LJ, Derman BA, Bal S, Sidana S, Chhabra S, Silbermann R, Ye JC, Cook G, Cornell RF, Holstein SA, Shi Q, Omel J, Callander NS, Chng WJ, Hungria V, Maiolino A, Stadtmauer E, Giralt S, Paquini M, Jakubowiak AJ, Morgan GJ, Krishnan A, Jackson GH, Mohty M, Mateos MV, Dimopoulos MA, Facon T, Spencer A, San Miguel J, Hari P, Usmani SZ, Manier S, McCarthy P, Kumar S, Gay F, Paiva B
|
Leukemia 35(1):18-30
|
2021
|
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.
|
Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, Schultz KR, Silverman LB, Whitlock JA, Wood B, Vainshtein I, Adams A, Confer D, Pulsipher MA, Chaudhury S, Wayne AS
|
Pediatr Blood Cancer 68(1):e28574
|